Cancer Cachexia Explained: New Research Shows Weight Loss Can Start Earlier Than Expected
When someone with cancer begins losing weight, the first explanation often seems obvious.
Maybe chemotherapy is causing nausea. Maybe mouth sores make eating painful. Maybe food tastes different. Maybe the patient simply doesn't have much of an appetite.
Those things can certainly cause weight loss.
But cancer can also trigger something more complicated called cancer cachexia.
Cachexia is not simply losing a few pounds because someone isn't eating enough. It is a whole-body condition in which cancer and the body's response to cancer can change metabolism, increase inflammation, and cause the body to break down muscle and fat.
A major new study published October 12, 2026, in Nature Medicine gives researchers one of the clearest pictures yet of how cancer-related weight loss develops over time.
Researchers analyzed approximately 1.7 million BMI measurements from 52,236 people with cancer.
They found that 46.6% of patients experienced at least one episode of significant weight loss meeting commonly used cachexia criteria.
The study also found something particularly important:
Cancer-related weight loss can begin much earlier than many people expect—even before cancer treatment starts.
The findings suggest that unexplained weight loss during cancer should not automatically be dismissed as an unavoidable side effect of treatment.
It may be an important clinical signal worth paying attention to.
What Is Cancer Cachexia?
Cancer cachexia is a condition that causes unplanned weight loss, muscle loss, weakness, and physical decline in some people with cancer.
The National Cancer Institute describes cachexia as a wasting syndrome involving loss of skeletal muscle and fat. It is often associated with weakness, fatigue, and loss of appetite.
But appetite is only part of the story.
Cancer cachexia can occur because cancer changes how the body manages:
Energy
Protein
Muscle
Fat
Hormones
Inflammation
Nutrients
This means a person can sometimes continue losing weight even when they are trying to eat enough.
That is what makes cachexia different from ordinary weight loss.
Cachexia Is Not Simply “Not Eating Enough”
Imagine two people who are losing weight.
The first person isn't consuming enough calories.
Their body begins using stored fat and muscle for energy.
If they begin eating enough food again, the body may be able to rebuild much of what was lost.
Now imagine a person with cancer cachexia.
That person may also be eating less, but something else is happening at the same time.
Cancer and cancer-related inflammation can change the body's metabolism and increase the breakdown of muscle and fat.
It is a little like trying to fill a bathtub while the drain is still open.
Adding more water helps.
But the problem isn't only the amount of water going into the tub. Something is also causing water to leave.
The same idea applies to cachexia.
Calories and protein still matter. Nutrition support still matters. But simply telling a patient to “eat more” may not solve the entire problem.
That is why cancer cachexia can be so difficult to treat.
Why Does Cancer Cause Cachexia?
Researchers are still working to fully understand cancer cachexia, but several processes appear to be involved.
Inflammation
Cancer can trigger inflammatory signals throughout the body.
Those signals may affect appetite, energy use, muscle, and fat.
Chronic inflammation can push the body toward breaking down tissue instead of maintaining or rebuilding it.
Changes in Metabolism
Cancer can also change how the body processes energy.
Some patients begin burning energy differently or breaking down muscle and fat faster than normal.
The body's normal balance between building and breaking down tissue shifts.
Reduced Appetite
Cancer itself can reduce appetite.
Treatment can add to the problem.
Nausea, pain, depression, anxiety, constipation, medications, changes in taste, and fatigue can all make someone less interested in food.
Cancer Treatment Side Effects
Cancer therapy can create additional barriers to nutrition.
Patients may experience:
Nausea
Vomiting
Diarrhea
Mouth sores
Oral mucositis
Painful swallowing
Dry mouth
Changes in taste
Feeling full quickly
Fatigue
These problems do not necessarily cause cachexia by themselves.
But they can make an existing problem much worse.
Why Muscle Loss Matters
Cancer cachexia is not just about pounds on a scale.
One of the most important concerns is loss of muscle.
Muscle allows people to:
Walk
Climb stairs
Get out of a chair
Maintain balance
Carry groceries
Perform normal daily activities
Maintain strength during illness
Losing significant amounts of muscle can leave patients weaker and reduce their physical reserve during cancer treatment.
This is also why BMI alone can be misleading.
A patient may still appear to have a normal weight—or even obesity—while losing important amounts of muscle.
Someone can therefore be experiencing serious cancer-related wasting without looking extremely thin.
What Did the New Nature Medicine Study Find?
Researchers at Memorial Sloan Kettering Cancer Center wanted to understand cancer-related weight loss as something that changes throughout the cancer journey.
Instead of simply asking whether a patient had cachexia at one point in time, they followed weight changes over many years.
The study included:
52,236 adults with cancer
1,741,505 BMI measurements
Multiple cancer types
Laboratory results
Tumor genetic information
Imaging showing disease progression
Researchers studied patients treated between 2010 and 2024.
They defined a qualifying weight-loss episode as:
At least 5% loss of body weight within six months, or
At least 2% weight loss in someone who started with a BMI below 20
Using those criteria, they identified 30,938 separate weight-loss episodes.
That enormous dataset allowed researchers to see patterns that smaller studies could easily miss.
Finding #1: Nearly Half of Cancer Patients Experienced Significant Weight Loss
Overall, 46.6% of patients experienced at least one significant weight-loss episode.
Among the patients who experienced weight loss, more than one in five had multiple episodes.
The average weight loss during an episode was about 10% of body weight.
That is significant.
For a 180-pound person, 10% represents about 18 pounds.
The researchers also found that weight loss was not always a smooth, continuous decline.
Some patients lost weight, stabilized, regained some weight, and later experienced another period of loss.
Meaningful weight regain occurred after about 27% of the weight-loss episodes.
This suggests cancer cachexia may sometimes behave more like a series of events than a single downhill slide.
That could change how doctors think about monitoring patients.
Finding #2: Pancreatic and Stomach Cancer Had Especially High Rates
The risk of significant weight loss varied widely depending on the type of cancer.
Some gastrointestinal cancers had particularly high rates.
Researchers found weight-loss episodes in approximately:
72.7% of patients with pancreatic adenocarcinoma
71.7% of patients with stomach adenocarcinoma
49.6% of patients with colorectal cancer
26.1% of patients with prostate cancer
The pancreatic and stomach cancer numbers are striking.
Roughly seven out of ten patients with those cancers experienced a qualifying episode of weight loss.
There may be several reasons.
Cancers involving the digestive system can affect:
Appetite
Digestion
Nutrient absorption
How quickly patients feel full
Gastrointestinal function
Surgery can change the digestive tract.
Cancer-related inflammation can alter metabolism.
Chemotherapy can further affect the gastrointestinal lining and appetite.
For these patients, maintaining nutrition can become particularly difficult.
Finding #3: Weight Loss Can Begin Before Chemotherapy Starts
This may be one of the most important findings in the entire study.
Many people assume cancer-related weight loss happens because of chemotherapy.
But researchers examined 20,554 patients with stage I through III cancer who had not yet received cancer treatment at diagnosis.
Within just 180 days of diagnosis, 23.2% experienced a qualifying weight-loss episode.
The numbers were much higher for some cancers:
Pancreatic cancer: 59.6%
Stomach cancer: 57.6%
That means major weight loss was already happening before chemotherapy or radiation could be blamed.
This helps reinforce what researchers have learned about cachexia:
Cancer itself can affect the entire body's metabolism.
Weight loss is not always simply a treatment side effect.
Finding #4: Weight Loss Often Occurred Around Cancer Progression
Researchers also compared weight-loss episodes with more than 212,000 imaging-confirmed cancer progression events.
In 17 of the 18 cancer types studied, disease progression occurred during weight-loss episodes more often than researchers would expect by chance.
That does not mean:
Weight loss = cancer progression.
People with cancer can lose weight for many reasons.
It also does not prove that weight loss causes cancer to become worse.
Instead, the relationship may work the other way around.
Progressing cancer may increase inflammation, alter metabolism, affect digestion, reduce appetite, or create symptoms that interfere with nutrition.
Still, the finding raises an important clinical question:
Could unexplained weight loss sometimes be an early sign that something about the disease is changing?
More research is needed, but the association is difficult to ignore.
Finding #5: Blood Tests Changed During Weight-Loss Episodes
The researchers found that cachexia-related weight loss was not happening in isolation.
Many routine blood tests changed at the same time.
During weight-loss episodes, patients tended to have lower:
Albumin
Total protein
Hemoglobin
Hematocrit
Red blood cell counts
Researchers also found changes in markers associated with inflammation and tissue stress.
Several important electrolytes—including sodium, potassium, and calcium—also tended to be lower.
For example, approximately 28% of albumin measurements during weight-loss episodes were below normal, compared with about 12% outside those episodes.
These findings don't prove cachexia caused those laboratory changes.
Chemotherapy and other health problems may contribute.
But they reinforce an important point:
Cancer cachexia is not simply weight disappearing from the body. It is associated with broader metabolic and physical changes.
Finding #6: Patients With Obesity Can Still Develop Serious Cachexia
Another important finding challenges the stereotype of what cachexia looks like.
Many people picture someone who is extremely thin.
But significant cancer-related weight loss occurred across BMI categories.
Among patients with obesity who experienced a qualifying episode:
44% lost at least 10% of their body weight
16.5% lost at least 15%
A patient can therefore remain technically overweight while losing a dangerous amount of weight and muscle.
Imagine someone who weighs 240 pounds and unintentionally loses 30 pounds during cancer treatment.
That person may still have a BMI classified as overweight.
But a 30-pound unintended loss is still clinically important.
This is why clinicians may need to pay more attention to weight trends than simply asking whether someone currently looks thin.
Finding #7: Tumor Genetics May Affect Cachexia Risk
The researchers also had access to detailed genetic information from patients' tumors.
That allowed them to ask an interesting question:
Could the biology of the tumor itself affect the risk of developing cachexia?
Researchers found 34 significant associations involving 23 tumor mutations across 14 types of cancer.
One gene appeared repeatedly:
TP53
TP53 mutations were associated with increased risk of weight-loss episodes across several cancers.
In colorectal cancer, mutations involving TP53, SMAD4, and KRAS were associated with higher risk.
These findings are early.
Patients should not interpret a TP53 or KRAS mutation as meaning they will develop cachexia.
But the discovery suggests that cancer cachexia may be influenced not only by where a cancer is located or how advanced it is, but also by the molecular biology of the tumor.
That could eventually help explain why two patients with seemingly similar cancers experience very different levels of weight and muscle loss.
Finding #8: Researchers Began Predicting Cachexia Before It Happened
Perhaps the most important long-term finding is that researchers were able to begin predicting which patients were more likely to experience future weight-loss episodes.
They created models using information such as:
Cancer stage
Starting BMI
Performance status
Tumor mutations
Clinical information
They developed models for:
Lung cancer
Colorectal cancer
Prostate cancer
They also tested parts of their approach in a separate group of 5,785 patients at Dana-Farber Cancer Institute.
The models were not perfect.
They are not currently available as routine clinical tools.
But they point toward a very different approach to cancer cachexia.
Today, the typical sequence might be:
Patient loses significant weight → doctors notice → supportive care begins.
In the future, the sequence might become:
Patient is identified as high-risk → nutrition and supportive care begin earlier → doctors monitor closely for changes.
That would move supportive cancer care from being reactive toward becoming more preventive.
Why Nutrition Still Matters
Learning that cachexia is metabolic does not mean nutrition is unimportant.
Quite the opposite.
Patients with cancer still need adequate:
Calories
Protein
Fluids
Electrolytes
Vitamins and minerals
The challenge is that patients with cachexia may need more than food alone.
A registered oncology dietitian can help identify problems such as:
Inadequate calorie intake
Low protein intake
Difficulty swallowing
Treatment-related nausea
Diarrhea
Vomiting
Mouth sores
Changes in taste
Feeling full too quickly
Treatment may also involve managing symptoms, maintaining activity when medically appropriate, treating the cancer itself, and sometimes using medications.
Cancer cachexia is usually a multifactorial problem, so it often needs a multifactorial response.
How Diarrhea, Vomiting and Mucositis Can Make the Problem Worse
One reason cachexia matters so much during cancer treatment is that cancer and treatment can create overlapping problems.
A patient may already be losing muscle because of cancer-related inflammation and metabolic changes.
Then chemotherapy causes nausea.
Eating drops.
Diarrhea leads to fluid and electrolyte losses.
Oral mucositis makes chewing and swallowing painful.
Food intake falls even further.
The patient becomes weaker.
This does not mean diarrhea, dehydration, or mouth sores cause cachexia.
But they can make an already difficult nutritional problem worse.
That is why supportive cancer care matters.
Managing treatment side effects is not simply about making someone more comfortable.
It may help patients maintain nutrition, hydration, strength, and the ability to continue treatment.
What Should Patients and Caregivers Watch For?
Cancer-related weight loss deserves attention before someone becomes visibly frail.
Tell the cancer care team about:
Unplanned weight loss
Clothes suddenly becoming loose
Loss of appetite
Visible muscle loss
Increasing weakness
Difficulty climbing stairs
Trouble getting out of a chair
Persistent nausea or vomiting
Diarrhea
Mouth sores
Pain when swallowing
Trouble staying hydrated
Reduced ability to perform normal activities
Don't assume these changes are simply something a cancer patient has to accept.
They should be evaluated.
Questions to Ask the Oncology Team
If weight or strength is declining, patients or caregivers may want to ask:
Is this amount of weight loss concerning?
Could this be cancer cachexia?
Am I losing muscle as well as fat?
Could the cancer itself be causing this weight loss?
Could treatment side effects be making it worse?
Can I see an oncology dietitian?
How much protein and how many calories should I be getting?
What should I do about nausea, diarrhea, vomiting, or mouth sores?
How can I stay hydrated?
How often should my weight and strength be monitored?
The sooner a problem is recognized, the more opportunity the care team has to respond.
Why This New Study Matters
The biggest contribution of the new Nature Medicine research may be that it changes the way we think about cancer cachexia.
Cachexia isn't necessarily:
Advanced cancer → steady weight loss → severe wasting.
The actual picture can be much more complicated.
Weight loss can:
Begin early
Happen before treatment
Occur in episodes
Improve temporarily
Return later
Occur in patients with obesity
Coincide with changes in blood tests
Occur around cancer progression
Be influenced by tumor genetics
And researchers may eventually be able to predict which patients are most at risk.
That means weight may be more than simply another measurement taken at the oncology clinic.
It could become an important part of understanding how the disease is affecting the whole patient.
The Bottom Line
Cancer cachexia is not simply losing weight because someone isn't eating enough.
It is a complex wasting condition involving muscle loss, fat loss, inflammation, metabolism, cancer biology, and often reduced food intake.
The new Nature Medicine study analyzed approximately 1.7 million weight measurements from 52,236 people with cancer.
Researchers found that:
46.6% experienced at least one significant weight-loss episode
72.7% of pancreatic cancer patients experienced an episode
71.7% of stomach cancer patients experienced an episode
49.6% of colorectal cancer patients experienced an episode
About 23% of untreated stage I–III patients developed significant weight loss within six months of diagnosis
Weight-loss episodes often occurred around cancer progression
Blood tests changed during these episodes
Certain tumor mutations were linked to greater risk
Researchers could begin predicting future weight-loss risk using clinical and genetic information
The findings do not mean every person who loses weight has cachexia.
They also do not mean weight loss proves cancer is progressing.
But they send a useful message to patients, caregivers, and healthcare professionals:
Unexplained weight loss during cancer deserves attention early.
Cancer treatment is not only about controlling the tumor.
It is also about helping the person maintain enough nutrition, hydration, strength, and physical reserve to get through treatment.
Frequently Asked Questions
What is cancer cachexia?
Cancer cachexia is a wasting syndrome in which a person with cancer loses weight, muscle, and often body fat. It involves changes in metabolism and inflammation and cannot usually be completely reversed simply by eating more food.
What is the difference between cachexia and normal weight loss?
Ordinary weight loss often happens because the body receives fewer calories than it needs. Cancer cachexia also involves metabolic and inflammatory changes that cause the body to break down muscle and fat. This is why nutrition alone may not completely reverse it.
Can cancer cachexia happen before chemotherapy?
Yes. In the new Nature Medicine study, about 23% of untreated patients with stage I–III cancer experienced a significant weight-loss episode within six months of diagnosis.
Which cancers have the highest rates of cachexia?
In the new study, pancreatic and stomach cancers had particularly high rates. About 73% of pancreatic cancer patients and 72% of stomach cancer patients experienced qualifying weight-loss episodes.
Does losing weight mean my cancer is progressing?
No. Weight loss can happen for many reasons. The study found that weight-loss episodes occurred around cancer progression more often than expected, but weight loss alone cannot tell whether cancer is progressing.
Can an overweight person develop cancer cachexia?
Yes. A person can still have overweight or obesity while losing a clinically important amount of weight and muscle. Changes over time are important.
Can chemotherapy make cachexia worse?
Cancer itself can drive cachexia, while treatment side effects such as nausea, vomiting, diarrhea, mouth sores, and appetite loss may make it harder for patients to maintain food and fluid intake.
Can eating more cure cancer cachexia?
Usually not by itself. Calories and protein remain important, but cancer cachexia involves inflammation and changes in metabolism. Treatment often requires nutrition support along with management of cancer and treatment-related symptoms.
Can doctors predict cancer cachexia?
Not routinely yet. The new study developed research models that could identify patients at increased risk of future weight-loss episodes using clinical and tumor information. More research is needed before these tools can be used routinely.
What should I do if I am losing weight during cancer treatment?
Tell your cancer care team. Ask whether the weight loss could be related to cachexia, malnutrition, dehydration, treatment side effects, or other medical problems and whether you should meet with an oncology dietitian.
References
Castillon VJ, Xie AX, Boscenco S, et al. A health-system-scale, episode-resolved multimodal atlas of cancer cachexia. Nature Medicine. Published October 12, 2026.
https://www.nature.com/articles/s41591-026-04689-9National Cancer Institute. Cancer Cachexia. Overview of cancer cachexia, symptoms, causes, and treatment.
https://www.cancer.gov/about-cancer/treatment/side-effects/cancer-cachexiaNational Cancer Institute. Nutrition in Cancer Care (PDQ®). Information on malnutrition, sarcopenia, cachexia, nutritional assessment, and nutrition support.
https://www.cancer.gov/about-cancer/treatment/side-effects/appetite-loss/nutrition-hp-pdqNational Cancer Institute. Nutrition During Cancer Treatment. Information on cancer and treatment-related nutrition problems.
https://www.cancer.gov/about-cancer/treatment/side-effects/nutritionNational Cancer Institute. Weight Changes, Malnutrition, and Cancer. Information on appetite loss, unintentional weight loss, and nutrition during treatment.
https://www.cancer.gov/about-cancer/treatment/side-effects/appetite-loss
For more information on how HuMOLYTE can support your gut health during chemotherapy, visit our product page or consult your health care provider.
This blog was reviewed by Dr. Sourabh Kharait.
This blog is for educational purposes only and is not intended as medical advice. Always consult with your healthcare provider before making any changes to your treatment plan, hydration strategies, or diet. The information provided here is based on general insights and may not apply to individual circumstances.
